MARKET

DHR

DHR

Danaher
NYSE

Real-time Quotes | Nasdaq Last Sale

247.02
+0.76
+0.31%
After Hours: 247.02 0 0.00% 17:05 06/11 EDT
OPEN
246.79
PREV CLOSE
246.26
HIGH
247.72
LOW
245.96
VOLUME
2.97M
TURNOVER
--
52 WEEK HIGH
261.43
52 WEEK LOW
164.51
MARKET CAP
176.19B
P/E (TTM)
38.90
1D
5D
1M
3M
1Y
5Y
Danaher Corp. stock rises Friday, outperforms market
marketwatch.com · 2d ago
With EPS Growth And More, Danaher (NYSE:DHR) Is Interesting
For beginners, it can seem like a good idea (and an exciting prospect) to buy a company that tells a good story to...
Simply Wall St. · 2d ago
Danaher Corp. stock outperforms market on strong trading day
marketwatch.com · 3d ago
5 Things You Might Not Know About New GameStop CEO Matt Furlong
On Wednesday, GameStop Corporation (NYSE: GME)
Benzinga · 3d ago
Danaher Stock Shows Every Sign Of Being Modestly Overvalued
GuruFocus News · 3d ago
10 Best Stocks to Buy According to Highbridge Capital
In this article we will take a look at the 10 best stocks to buy according to billionaire Glenn Russell Dubin’s Highbridge Capital Management. You can skip our detailed analysis of Dubin’s history, investment philosophy, and hedge fund performance, and go ...
Insider Monkey · 3d ago
Danaher Corp. stock underperforms Wednesday when compared to competitors despite daily gains
marketwatch.com · 4d ago
Danaher (DHR) is an Incredible Growth Stock: 3 Reasons Why
Zacks.com · 4d ago
More
Forecast
Actual (USD)
Estimate (USD)
Income StatementMore
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
Operating (USD)
YoY (%)
Learn about the latest financial forecast of DHR. Analyze the recent business situations of Danaher through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 24 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average DHR stock price target is 291.74 with a high estimate of 325.00 and a low estimate of 270.00.
EPS
Institutional Holdings
Institutions: 2.17K
Institutional Holdings: 599.99M
% Owned: 84.12%
Shares Outstanding: 713.28M
TypeInstitutionsShares
Increased
656
20.20M
New
106
2.90M
Decreased
694
18.70M
Sold Out
110
1.20M
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Advanced Medical Equipment & Technology
+0.27%
Healthcare Equipment & Supplies
+0.06%
Key Executives
Chairman/Director
Steven Rales
President/Chief Executive Officer/Director
Rainer Blair
Co-Founder/Director
Mitchell Rales
Chief Financial Officer/Executive Vice President
Matthew McGrew
Executive Vice President
Jennifer Honeycutt
Executive Vice President
Joakim Weidemanis
Senior Vice President/Chief Accounting Officer
Robert Lutz
Senior Vice President/Chief Scientific Officer
Jose-Carlos Gutierrez-Ramos
Senior Vice President/General Counsel
Brian Ellis
Senior Vice President/Director of Human Resources
Angela Lalor
Senior Vice President
William King
Senior Vice President
Daniel Raskas
Lead Director/Independent Director
Linda Hefner Filler
Director
A. Shane Sanders
Independent Director
Teri List-Stoll
Independent Director
Walter Lohr
Independent Director
Walter Lohr,
Independent Director
Jessica Mega
Independent Director
Pardis Sabeti
Independent Director
John Schwieters
Independent Director
Alan Spoon
Independent Director
Raymond Stevens
Independent Director
Elias Zerhouni,
Independent Director
Elias Zerhouni
Declaration Date
Dividend Per Share
Ex-Div Date
05/05/2021
Dividend USD 0.21
06/24/2021
02/23/2021
Dividend USD 0.21
03/25/2021
12/08/2020
Dividend USD 0.18
12/24/2020
09/15/2020
Dividend USD 0.18
09/25/2020
05/05/2020
Dividend USD 0.18
06/25/2020
02/20/2020
Dividend USD 0.18
03/26/2020
12/10/2019
Dividend USD 0.17
12/26/2019
09/10/2019
Dividend USD 0.17
09/26/2019
05/07/2019
Dividend USD 0.17
06/27/2019
03/08/2019
Dividend USD 0.17
03/28/2019
12/03/2018
Dividend USD 0.16
12/27/2018
09/11/2018
Dividend USD 0.16
09/27/2018
05/08/2018
Dividend USD 0.16
06/28/2018
02/20/2018
Dividend USD 0.16
03/28/2018
12/05/2017
Dividend USD 0.14
12/28/2017
09/12/2017
Dividend USD 0.14
09/28/2017
05/10/2017
Dividend USD 0.14
06/28/2017
02/22/2017
Dividend USD 0.14
03/29/2017
12/07/2016
Dividend USD 0.125
12/28/2016
09/14/2016
Dividend USD 0.125
09/28/2016
  • All
  • Financials
  • Insiders
More
About DHR
Danaher Corporation (Danaher) designs, manufactures and markets professional, medical, industrial and commercial products and services. The Company operates through three segments: Life Sciences, which offers a range of research tools that scientists use to study the basic building blocks of life, including genes, proteins, metabolites and cells, in order to understand the causes of disease, identify new therapies and test new drugs and vaccines; Diagnostics; which offers analytical instruments, reagents, consumables, software and services; and Environmental & Applied Solutions, which consists of various lines of business, including water quality and product identification. Danaher's research and development, manufacturing, sales, distribution, service and administrative facilities were located in over 60 countries.

Webull offers kinds of Danaher Corporation stock information, including NYSE:DHR real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, DHR stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading DHR stock methods without spending real money on the virtual paper trading platform.